WARREN, R.; BLAUVELT, A.; BAGEL, J.; PAPP, K.; YAMAUCHI, P.; ARMSTRONG, A.; LANGLEY, R.; VANVOORDEN, V.; DE CUYPER, D.; PETERSON, L.; CROSS, N.; REICH, K. Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s15, 2021. DOI: 10.25251/skin.5.supp.15. Disponível em: https://jofskin.org/index.php/skin/article/view/1168. Acesso em: 12 jul. 2024.